Clinical Trials
4 trialsNCT00084656 2022-04-14
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Bristol-Myers Squibb
Phase 2 Completed
NCT00028431 2014-05-22
Novel Adjuvants for Peptide-Based Melanoma Vaccines
University of Southern California
Phase 1 Completed
NCT00313508 2014-02-21
Dendritic Cell Vaccination During Lymphoid Reconstruction
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00001685 2008-03-04
Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
National Institutes of Health Clinical Center (CC)
Phase 2 Completed